speb/financial-data huggingface dataset:
IPDN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 151267.00
IPDN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 162165.00
IPDN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 98697.00
IPDN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 240846.00
IPDN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 98697.00
IPDN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1022754.00
IPDN balance_sheet (quarterly, 2026-03-31) — Common Stock: 102449.00
IPDN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 13918626.00
IPDN cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 1205000.00
IPDN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1013335.00
IPDN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1358978.00
IPDN balance_sheet (quarterly, 2026-03-31) — Current Assets: 3336597.00
IPDN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 104743.00
IPDN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 104743.00
IPDN balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1078526.00
IPDN balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1078526.00
IPDN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4124136.00
IPDN cash_flow (quarterly, 2026-03-31) — Depreciation: 3055.00
IPDN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1195750.00
IPDN income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 1195751.00
IPDN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1195750.00
IPDN income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1195751.00
IPDN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 9587283.00
IPDN income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.19
IPDN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -1854997.00
IPDN income_statement (quarterly, 2026-03-31) — EBIT: -1853582.00
IPDN income_statement (quarterly, 2026-03-31) — EBITDA: -657831.00
IPDN cash_flow (quarterly, 2026-03-31) — End Cash Position: 2489708.00
IPDN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1385000.00
IPDN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -362246.00
IPDN cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 18507.00
IPDN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 771967.00
IPDN balance_sheet (quarterly, 2026-03-31) — Goodwill: 1417753.00
IPDN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 10193353.00
IPDN balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 877248.00
IPDN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 144202.00
IPDN income_statement (quarterly, 2026-03-31) — Gross Profit: 534741.00
IPDN cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
IPDN income_statement (quarterly, 2026-03-31) — Interest Expense: 2529.00
IPDN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2529.00
IPDN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 13918626.00
IPDN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
IPDN cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 1205000.00
IPDN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 55400.00
IPDN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 55400.00
IPDN balance_sheet (quarterly, 2026-03-31) — Minority Interest: -568255.00
IPDN income_statement (quarterly, 2026-03-31) — Minority Interests: 1114.00
IPDN cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 1205000.00
IPDN income_statement (quarterly, 2026-03-31) — Net Income: -1854997.00
IPDN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -1854997.00
IPDN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1856111.00
IPDN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1854997.00
IPDN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1854997.00
IPDN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -1856111.00
IPDN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1856111.00
IPDN cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
IPDN income_statement (quarterly, 2026-03-31) — Net Interest Income: -2529.00
IPDN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
IPDN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 180000.00
IPDN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2529.00
IPDN balance_sheet (quarterly, 2026-03-31) — Net PPE: 144202.00
IPDN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
IPDN cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 180000.00
IPDN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3725273.00
IPDN balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 49755.00
IPDN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -657831.00
IPDN income_statement (quarterly, 2026-03-31) — Normalized Income: -1854997.00
IPDN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -362246.00
IPDN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 18507.00
IPDN income_statement (quarterly, 2026-03-31) — Operating Income: -1853582.00
IPDN income_statement (quarterly, 2026-03-31) — Operating Revenue: 1548076.00
IPDN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 10244785.00
IPDN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 123018.00
IPDN balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 718152.00
IPDN income_statement (quarterly, 2026-03-31) — Other Gand A: 771967.00
IPDN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 8775600.00
IPDN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 22848.00
IPDN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3806000.00
IPDN balance_sheet (quarterly, 2026-03-31) — Other Properties: 144202.00
IPDN balance_sheet (quarterly, 2026-03-31) — Payables: 863737.00
IPDN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2222715.00
IPDN income_statement (quarterly, 2026-03-31) — Pretax Income: -1856111.00
IPDN cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -14908.00
IPDN cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: 0.00
IPDN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
IPDN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
IPDN balance_sheet (quarterly, 2026-03-31) — Receivables: 723871.00
IPDN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1013336.00
IPDN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1195750.00
IPDN balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 2455000.00
IPDN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -110720671.00
IPDN income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 420605.00
IPDN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1192572.00
IPDN balance_sheet (quarterly, 2026-03-31) — Share Issued: 10244837.00
IPDN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 30822.00
IPDN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 13918626.00
IPDN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3725273.00
IPDN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IPDN income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
IPDN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
IPDN balance_sheet (quarterly, 2026-03-31) — Total Assets: 17529907.00
IPDN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 13918626.00
IPDN balance_sheet (quarterly, 2026-03-31) — Total Debt: 160143.00
IPDN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 13350371.00
IPDN income_statement (quarterly, 2026-03-31) — Total Expenses: 3401658.00
IPDN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4179536.00
IPDN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 14193310.00
IPDN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 55400.00
IPDN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1856111.00
IPDN balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 52.00
IPDN balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 37117.00
IPDN cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
IPDN balance_sheet (quarterly, 2026-03-31) — Working Capital: -787539.00
IPEX balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 24195.00
IPEX income_statement (quarterly, 2024-09-30) — Basic Average Shares: 10600000.00
IPEX income_statement (quarterly, 2024-09-30) — Basic EPS:
IPEX balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 0.00
IPEX income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 10600000.00
IPEX income_statement (quarterly, 2024-09-30) — Diluted EPS:
IPEX balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 94165.00
IPEX balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 114602.00
IPEX balance_sheet (quarterly, 2024-09-30) — Preferred Stock: 0.00
IPEX income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
IPEX income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: -365.00
IPEX income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
IPEX income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Accounts Payable: 3124.00
IPEX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 24698.00
IPEX balance_sheet (annual, 2024-12-31) — Capital Stock: 302.00
IPEX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Cash Financial: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Common Stock: 302.00
IPEX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 17288.00
IPEX balance_sheet (annual, 2024-12-31) — Current Assets: 131602.00
IPEX balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 131602.00
IPEX balance_sheet (annual, 2024-12-31) — Current Liabilities: 114314.00
IPEX balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 111190.00
IPEX balance_sheet (annual, 2024-12-31) — Invested Capital: 17288.00
IPEX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 17288.00
IPEX balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 131602.00
IPEX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 10756250.00
IPEX balance_sheet (annual, 2024-12-31) — Payables: 114314.00
IPEX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 114314.00
IPEX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Retained Earnings: -7712.00
IPEX balance_sheet (annual, 2024-12-31) — Share Issued: 10756250.00
IPEX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 17288.00
IPEX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 17288.00
IPEX balance_sheet (annual, 2024-12-31) — Total Assets: 131602.00
IPEX balance_sheet (annual, 2024-12-31) — Total Capitalization: 17288.00
IPEX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 17288.00
IPEX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 114314.00
IPEX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IPEX balance_sheet (annual, 2024-12-31) — Working Capital: 17288.00
IPEX income_statement (quarterly, 2025-03-31) — +Operating Expense: 40423.00
IPEX income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
IPEX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 16537.00
IPEX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 7379719.00
IPEX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.05
IPEX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 0.00
IPEX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 86667538.00
IPEX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 504566.00
IPEX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 504566.00
IPEX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 86972868.00
IPEX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -86250000.00
IPEX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -218301.00
IPEX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 13413.00
IPEX cash_flow (quarterly, 2025-03-31) — Change In Payable: -95276.00
IPEX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -95276.00
IPEX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -85753.00
IPEX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -181029.00
IPEX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 504566.00
IPEX balance_sheet (quarterly, 2025-03-31) — Common Stock: 86667538.00
IPEX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 83288491.00
IPEX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 88906250.00
IPEX balance_sheet (quarterly, 2025-03-31) — Current Assets: 590319.00
IPEX balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 0.00
IPEX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19038.00
IPEX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 7379719.00
IPEX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.05
IPEX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 379937.00
IPEX balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 2501.00
IPEX income_statement (quarterly, 2025-03-31) — EBIT: -40423.00
IPEX income_statement (quarterly, 2025-03-31) — EBITDA: -40423.00
IPEX cash_flow (quarterly, 2025-03-31) — End Cash Position: 504566.00
IPEX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 86972867.00
IPEX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -218301.00
IPEX income_statement (quarterly, 2025-03-31) — Interest Income: 420360.00
IPEX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 420360.00
IPEX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 83788491.00
IPEX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -86250000.00
IPEX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 88906250.00
IPEX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 500000.00
IPEX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 500000.00
IPEX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 88906250.00
IPEX income_statement (quarterly, 2025-03-31) — Net Income: 379937.00
IPEX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 379937.00
IPEX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 379937.00
IPEX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 379937.00
IPEX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 379937.00
IPEX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 379937.00
IPEX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 379937.00
IPEX income_statement (quarterly, 2025-03-31) — Net Interest Income: 420360.00
IPEX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 500000.00
IPEX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 500000.00
IPEX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 420360.00
IPEX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2433383.00
IPEX cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -86250000.00
IPEX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 83288491.00
IPEX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 3450000.00
IPEX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -40423.00
IPEX income_statement (quarterly, 2025-03-31) — Normalized Income: 379937.00
IPEX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -218301.00
IPEX income_statement (quarterly, 2025-03-31) — Operating Income: -40423.00
IPEX income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
IPEX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 11909375.00
IPEX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -417209.00
IPEX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 86667209.00
IPEX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -1.00
IPEX income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 40423.00
IPEX balance_sheet (quarterly, 2025-03-31) — Payables: 19038.00
IPEX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 19038.00
IPEX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 85753.00
IPEX income_statement (quarterly, 2025-03-31) — Pretax Income: 379937.00
IPEX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -3379047.00
IPEX balance_sheet (quarterly, 2025-03-31) — Share Issued: 11909375.00
IPEX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 83288491.00
IPEX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 83288491.00
IPEX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IPEX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
IPEX balance_sheet (quarterly, 2025-03-31) — Total Assets: 87257528.00
IPEX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 83788491.00
IPEX balance_sheet (quarterly, 2025-03-31) — Total Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 83288491.00
IPEX income_statement (quarterly, 2025-03-31) — Total Expenses: 40423.00
IPEX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3969037.00
IPEX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 86667209.00
IPEX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3949999.00
IPEX balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 3450000.00
IPEX balance_sheet (quarterly, 2025-03-31) — Working Capital: 571281.00
IPEX income_statement (quarterly, 2025-06-30) — +Operating Expense: 46942.00
IPEX income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
IPEX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 16010.00
IPEX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 0.00
IPEX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 11909375.00
IPEX income_statement (quarterly, 2025-06-30) — Basic EPS: 0.07
IPEX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 504566.00
IPEX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 87571123.00
IPEX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 496072.00
IPEX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 496072.00
IPEX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 4156.00
IPEX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
IPEX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -12650.00
IPEX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -527.00
IPEX cash_flow (quarterly, 2025-06-30) — Change In Payable: 4473.00
IPEX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 4473.00
IPEX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 24951.00
IPEX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 29424.00
IPEX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -8494.00
IPEX balance_sheet (quarterly, 2025-06-30) — Common Stock: 87571123.00
IPEX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 84154158.00
IPEX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
IPEX balance_sheet (quarterly, 2025-06-30) — Current Assets: 556874.00
IPEX balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 0.00
IPEX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 23511.00
IPEX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 11909375.00
IPEX income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.07
IPEX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 861511.00
IPEX balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 7501.00
IPEX income_statement (quarterly, 2025-06-30) — EBIT: -46942.00
IPEX income_statement (quarterly, 2025-06-30) — EBITDA: -46942.00
IPEX cash_flow (quarterly, 2025-06-30) — End Cash Position: 496072.00
IPEX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 4156.00
IPEX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -12650.00
IPEX income_statement (quarterly, 2025-06-30) — Interest Income: 908453.00
IPEX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 908453.00
IPEX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 84654158.00
IPEX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
IPEX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
IPEX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
IPEX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 500000.00
IPEX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
IPEX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
IPEX balance_sheet (quarterly, 2025-06-30) — Net Debt: 3928.00
IPEX income_statement (quarterly, 2025-06-30) — Net Income: 861511.00
IPEX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 861511.00
IPEX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 861511.00
IPEX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 861511.00
IPEX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 861511.00
IPEX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 861511.00
IPEX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 861511.00
IPEX income_statement (quarterly, 2025-06-30) — Net Interest Income: 908453.00
IPEX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
IPEX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
IPEX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 908453.00
IPEX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 4156.00
IPEX cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
IPEX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 84154158.00
IPEX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3450000.00
IPEX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -46942.00
IPEX income_statement (quarterly, 2025-06-30) — Normalized Income: 861511.00
IPEX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -12650.00
IPEX income_statement (quarterly, 2025-06-30) — Operating Income: -46942.00
IPEX income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
IPEX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 14928125.00
IPEX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -903585.00
IPEX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 87570794.00
IPEX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: -1.00
IPEX income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 46942.00
IPEX balance_sheet (quarterly, 2025-06-30) — Payables: 23511.00
IPEX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 23511.00
IPEX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
IPEX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 60802.00
IPEX income_statement (quarterly, 2025-06-30) — Pretax Income: 861511.00
IPEX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -3416965.00
IPEX balance_sheet (quarterly, 2025-06-30) — Share Issued: 14928125.00
IPEX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 84154158.00
IPEX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 84154158.00
IPEX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IPEX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
IPEX balance_sheet (quarterly, 2025-06-30) — Total Assets: 88127668.00
IPEX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 84654158.00
IPEX balance_sheet (quarterly, 2025-06-30) — Total Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 84154158.00
IPEX income_statement (quarterly, 2025-06-30) — Total Expenses: 46942.00
IPEX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3973510.00
IPEX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 87570794.00
IPEX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3949999.00
IPEX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -46942.00
IPEX balance_sheet (quarterly, 2025-06-30) — Working Capital: 533363.00
IPEX income_statement (quarterly, 2025-09-30) — +Operating Expense: 859045.00
IPEX income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
IPEX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 660725.00
IPEX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 0.00
IPEX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 11920136.00
IPEX income_statement (quarterly, 2025-09-30) — Basic EPS: 0.01
IPEX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 496072.00
IPEX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 88486017.00
IPEX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 289580.00
IPEX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 289580.00
IPEX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
IPEX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
IPEX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -206493.00
IPEX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 644715.00
IPEX cash_flow (quarterly, 2025-09-30) — Change In Payable: 637214.00
IPEX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 637214.00
IPEX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 296.00
IPEX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 637510.00
IPEX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -206492.00
IPEX balance_sheet (quarterly, 2025-09-30) — Common Stock: 88486017.00
IPEX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 84225049.00
IPEX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
IPEX balance_sheet (quarterly, 2025-09-30) — Current Assets: 350086.00
IPEX balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 0.00
IPEX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 660725.00
IPEX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 11920136.00
IPEX income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.01
IPEX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 70891.00
IPEX balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 0.00
IPEX income_statement (quarterly, 2025-09-30) — EBIT: -859045.00
IPEX income_statement (quarterly, 2025-09-30) — EBITDA: -859045.00
IPEX cash_flow (quarterly, 2025-09-30) — End Cash Position: 289580.00
IPEX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1.00
IPEX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -206493.00
IPEX income_statement (quarterly, 2025-09-30) — Interest Income: 917434.00
IPEX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 917434.00
IPEX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 84725049.00
IPEX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
IPEX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
IPEX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
IPEX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 500000.00
IPEX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
IPEX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
IPEX balance_sheet (quarterly, 2025-09-30) — Net Debt: 210420.00
IPEX income_statement (quarterly, 2025-09-30) — Net Income: 70891.00
IPEX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 70891.00
IPEX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 70891.00
IPEX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 70891.00
IPEX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 70891.00
IPEX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 70891.00
IPEX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 70891.00
IPEX income_statement (quarterly, 2025-09-30) — Net Interest Income: 917434.00
IPEX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
IPEX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
IPEX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 917434.00
IPEX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 1.00
IPEX cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
IPEX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 84225049.00
IPEX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3450000.00
IPEX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -871547.00
IPEX income_statement (quarterly, 2025-09-30) — Normalized Income: 61014.42
IPEX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -206493.00
IPEX income_statement (quarterly, 2025-09-30) — Operating Income: -859045.00
IPEX income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
IPEX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 11909375.00
IPEX income_statement (quarterly, 2025-09-30) — Other Income Expense: 12502.00
IPEX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -914894.00
IPEX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 88485688.00
IPEX income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 859045.00
IPEX income_statement (quarterly, 2025-09-30) — Other Special Charges: -12502.00
IPEX balance_sheet (quarterly, 2025-09-30) — Payables: 660725.00
IPEX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 660725.00
IPEX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
IPEX balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 60506.00
IPEX income_statement (quarterly, 2025-09-30) — Pretax Income: 70891.00
IPEX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -4260968.00
IPEX balance_sheet (quarterly, 2025-09-30) — Share Issued: 11909375.00
IPEX income_statement (quarterly, 2025-09-30) — Special Income Charges: 12502.00
IPEX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 84225049.00
IPEX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 84225049.00
IPEX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 2625.42
IPEX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
IPEX balance_sheet (quarterly, 2025-09-30) — Total Assets: 88835774.00
IPEX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 84725049.00
IPEX balance_sheet (quarterly, 2025-09-30) — Total Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 84225049.00
IPEX income_statement (quarterly, 2025-09-30) — Total Expenses: 859045.00
IPEX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4610725.00
IPEX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 88485688.00
IPEX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3950000.00
IPEX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -859045.00
IPEX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 12502.00
IPEX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 12502.00
IPEX balance_sheet (quarterly, 2025-09-30) — Working Capital: -310639.00
IPEX income_statement (annual, 2025-12-31) — +Operating Expense: 2717289.00
IPEX income_statement (quarterly, 2025-12-31) — +Operating Expense: 1770879.00
IPEX income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
IPEX income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Accounts Payable: 2268470.00
IPEX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2268470.00
IPEX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 0.00
IPEX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 0.00
IPEX income_statement (annual, 2025-12-31) — Basic Average Shares: 10807712.00
IPEX income_statement (annual, 2025-12-31) — Basic EPS: 0.04
IPEX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 0.00
IPEX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 289580.00
IPEX balance_sheet (annual, 2025-12-31) — Capital Stock: 89339619.00
IPEX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 89339619.00
IPEX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 25745.00
IPEX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 25745.00
IPEX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 25745.00
IPEX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 25745.00
IPEX balance_sheet (annual, 2025-12-31) — Cash Financial: 25745.00
IPEX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 25745.00
IPEX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 86977023.00
IPEX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1.00
IPEX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -86250000.00
IPEX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
IPEX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -701278.00
IPEX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -263834.00
IPEX cash_flow (annual, 2025-12-31) — Change In Account Payable: 2265347.00
IPEX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1607746.00
IPEX cash_flow (annual, 2025-12-31) — Change In Payable: 2154157.00
IPEX cash_flow (quarterly, 2025-12-31) — Change In Payable: 1607746.00
IPEX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2154157.00
IPEX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1607746.00
IPEX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -163017.00
IPEX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -102511.00
IPEX cash_flow (annual, 2025-12-31) — Change In Working Capital: 1991140.00
IPEX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1505235.00
IPEX cash_flow (annual, 2025-12-31) — Changes In Cash: 25745.00
IPEX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -263835.00
IPEX balance_sheet (annual, 2025-12-31) — Common Stock: 89339619.00
IPEX balance_sheet (quarterly, 2025-12-31) — Common Stock: 89339619.00
IPEX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 83309582.00
IPEX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 83309582.00
IPEX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 88906250.00
IPEX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Current Assets: 188762.00
IPEX balance_sheet (quarterly, 2025-12-31) — Current Assets: 188762.00
IPEX balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 0.00
IPEX balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Current Liabilities: 2268470.00
IPEX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2268470.00
IPEX income_statement (annual, 2025-12-31) — Diluted Average Shares: 10807712.00
IPEX income_statement (annual, 2025-12-31) — Diluted EPS: 0.04
IPEX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 396872.00
IPEX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -915467.00
IPEX balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 0.00
IPEX balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 0.00
IPEX income_statement (annual, 2025-12-31) — EBIT: -2717289.00
IPEX income_statement (quarterly, 2025-12-31) — EBIT: -1770879.00
IPEX income_statement (annual, 2025-12-31) — EBITDA: -2717289.00
IPEX income_statement (quarterly, 2025-12-31) — EBITDA: -1770879.00
IPEX cash_flow (annual, 2025-12-31) — End Cash Position: 25745.00
IPEX cash_flow (quarterly, 2025-12-31) — End Cash Position: 25745.00
IPEX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 86977023.00
IPEX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1.00
IPEX cash_flow (annual, 2025-12-31) — Free Cash Flow: -701278.00
IPEX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -263834.00
IPEX income_statement (annual, 2025-12-31) — Interest Income: 3101659.00
IPEX income_statement (quarterly, 2025-12-31) — Interest Income: 855412.00
IPEX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3101659.00
IPEX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 855412.00
IPEX balance_sheet (annual, 2025-12-31) — Invested Capital: 83809582.00
IPEX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 83809582.00
IPEX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -86250000.00
IPEX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
IPEX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 88906250.00
IPEX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
IPEX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 500000.00
IPEX cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Long Term Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 500000.00
IPEX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 500000.00
IPEX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 500000.00
IPEX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 500000.00
IPEX cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
IPEX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 88906250.00
IPEX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Net Debt: 474255.00
IPEX balance_sheet (quarterly, 2025-12-31) — Net Debt: 474255.00
IPEX income_statement (annual, 2025-12-31) — Net Income: 396872.00
IPEX income_statement (quarterly, 2025-12-31) — Net Income: -915467.00
IPEX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 396872.00
IPEX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -915467.00
IPEX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 396872.00
IPEX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -915467.00
IPEX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 396872.00
IPEX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -915467.00
IPEX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 396872.00
IPEX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -915467.00
IPEX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 396872.00
IPEX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -915467.00
IPEX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 396872.00
IPEX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -915467.00
IPEX income_statement (annual, 2025-12-31) — Net Interest Income: 3101659.00
IPEX income_statement (quarterly, 2025-12-31) — Net Interest Income: 855412.00
IPEX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 500000.00
IPEX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
IPEX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 500000.00
IPEX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
IPEX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3101659.00
IPEX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 855412.00
IPEX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2429227.00
IPEX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1.00
IPEX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -86250000.00
IPEX cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 83309582.00
IPEX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 83309582.00
IPEX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 3450000.00
IPEX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 3450000.00
IPEX income_statement (annual, 2025-12-31) — Normalized EBITDA: -2729791.00
IPEX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1770879.00
IPEX income_statement (annual, 2025-12-31) — Normalized Income: 386995.42
IPEX income_statement (quarterly, 2025-12-31) — Normalized Income: -915467.00
IPEX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -701278.00
IPEX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -263834.00
IPEX income_statement (annual, 2025-12-31) — Operating Income: -2717289.00
IPEX income_statement (quarterly, 2025-12-31) — Operating Income: -1770879.00
IPEX income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
IPEX income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 11909375.00
IPEX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 11909375.00
IPEX income_statement (annual, 2025-12-31) — Other Income Expense: 12502.00
IPEX income_statement (quarterly, 2025-12-31) — Other Income Expense: 0.00
IPEX cash_flow (annual, 2025-12-31) — Other Non Cash Items: -3089290.00
IPEX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -853602.00
IPEX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 89339290.00
IPEX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 89339290.00
IPEX income_statement (annual, 2025-12-31) — Other Operating Expenses: 2717289.00
IPEX income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1770879.00
IPEX income_statement (annual, 2025-12-31) — Other Special Charges: -12502.00
IPEX income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Payables: 2268470.00
IPEX balance_sheet (quarterly, 2025-12-31) — Payables: 2268470.00
IPEX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2268470.00
IPEX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2268470.00
IPEX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
IPEX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 163017.00
IPEX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 163017.00
IPEX income_statement (annual, 2025-12-31) — Pretax Income: 396872.00
IPEX income_statement (quarterly, 2025-12-31) — Pretax Income: -915467.00
IPEX balance_sheet (annual, 2025-12-31) — Retained Earnings: -6030037.00
IPEX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -6030037.00
IPEX income_statement (annual, 2025-12-31) — Selling General And Administration: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Share Issued: 11909375.00
IPEX balance_sheet (quarterly, 2025-12-31) — Share Issued: 11909375.00
IPEX income_statement (annual, 2025-12-31) — Special Income Charges: 12502.00
IPEX income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 83309582.00
IPEX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 83309582.00
IPEX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 83309582.00
IPEX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 83309582.00
IPEX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 2625.42
IPEX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IPEX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
IPEX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
IPEX balance_sheet (annual, 2025-12-31) — Total Assets: 89528052.00
IPEX balance_sheet (quarterly, 2025-12-31) — Total Assets: 89528052.00
IPEX balance_sheet (annual, 2025-12-31) — Total Capitalization: 83809582.00
IPEX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 83809582.00
IPEX balance_sheet (annual, 2025-12-31) — Total Debt: 500000.00
IPEX balance_sheet (quarterly, 2025-12-31) — Total Debt: 500000.00
IPEX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 83309582.00
IPEX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 83309582.00
IPEX income_statement (annual, 2025-12-31) — Total Expenses: 2717289.00
IPEX income_statement (quarterly, 2025-12-31) — Total Expenses: 1770879.00
IPEX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6218470.00
IPEX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6218470.00
IPEX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 89339290.00
IPEX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 89339290.00
IPEX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3950000.00
IPEX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3950000.00
IPEX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -2717289.00
IPEX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -1770879.00
IPEX income_statement (annual, 2025-12-31) — Total Unusual Items: 12502.00
IPEX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
IPEX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 12502.00